1. Acute myeloid leukemia-induced functional inhibition of healthy CD34+ hematopoietic stem and progenitor cells. (20th May 2021) Authors: Jäger, Paul; Geyh, Stefanie; Twarock, Sören; Cadeddu, Ron-Patrick; Rabes, Pablo; Koch, Annemarie; Maus, Uwe; Hesper, Tobias; Zilkens, Christoph; Rautenberg, Christina; Bormann, Felix; Köhrer, Karl; Petzsch, Patrick; Wieczorek, Dagmar; Betz, Beate; Surowy, Harald; Hildebrandt, Barbara; Germing, Ul... Journal: Stem cells Issue: Volume 39:Number 9(2021) Page Start: 1270 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Acute myeloid leukemia‐induced functional inhibition of healthy CD34+ hematopoietic stem and progenitor cells. (20th May 2021) Authors: Jäger, Paul; Geyh, Stefanie; Twarock, Sören; Cadeddu, Ron‐Patrick; Rabes, Pablo; Koch, Annemarie; Maus, Uwe; Hesper, Tobias; Zilkens, Christoph; Rautenberg, Christina; Bormann, Felix; Köhrer, Karl; Petzsch, Patrick; Wieczorek, Dagmar; Betz, Beate; Surowy, Harald; Hildebrandt, Barbara; Germing, Ul... Journal: Stem cells Issue: Volume 39:Number 9(2021) Page Start: 1270 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Azacitidine and donor lymphocytes infusions in acute myeloid leukemia and myelodysplastic syndrome relapsed after allogeneic hematopoietic stem cell transplantation from alternative donors. (June 2022) Authors: Liberatore, Carmine; Stanghellini, Maria Teresa Lupo; Lorentino, Francesca; Vago, Luca; Carrabba, Matteo Giovanni; Greco, Raffaella; Marktel, Sarah; Assanelli, Andrea; Farina, Francesca; Corti, Consuelo; Bernardi, Massimo; Peccatori, Jacopo; Sockel, Katja; Middeke, Jan Moritz; Schetelig, Johannes... Journal: Therapeutic advances in hematology Issue: Volume 13(2022) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Do hypomethylating agents prevent relapse after Allo‐HCT?. Issue 1 (29th November 2018) Authors: Schroeder, Thomas; Rautenberg, Christina; Haas, Rainer; Germing, Ulrich; Kobbe, Guido Journal: Advances in cell and gene therapy Issue: Volume 2:Issue 1(2019) Page Start: n/a Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Eligibility for clinical trials is unsatisfactory for patients with myelodysplastic syndromes, even at a tertiary referral center. (September 2021) Authors: Nachtkamp, Kathrin; Stark, Josefine; Kündgen, Andrea; Schroeder, Thomas; Strupp, Corinna; Strapatsas, Judith; Schuler, Esther; Kaivers, Jennifer; Giagounidis, Aristoteles; Rautenberg, Christina; Aul, Carlo; Runde, Volker; Haas, Rainer; Kobbe, Guido; Gattermann, Norbert; Germing, Ulrich Journal: Leukemia research Issue: Volume 108(2021) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. High Molecular and Cytogenetic Risk in Myelofibrosis Does Not Benefit From Higher Intensity Conditioning Before Hematopoietic Cell Transplantation: An International Collaborative Analysis. Issue 10 (30th October 2022) Authors: Gagelmann, Nico; Salit, Rachel B.; Schroeder, Thomas; Badbaran, Anita; Rautenberg, Christina; Panagiota, Victoria; Wolschke, Christine; Thol, Felicitas; Cassinat, Bruno; Robin, Marie; Heuser, Michael; Reinhardt, Hans Christian; Scott, Bart L.; Kröger, Nicolaus Journal: HemaSphere Issue: Volume 6:Issue 10(2022) Page Start: e784 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. Improving the accuracy of prognostication in chronic myelomonocytic leukemia. Issue 8 (2nd August 2020) Authors: Kaivers, Jennifer; Schuler, Esther; Hildebrandt, Barbara; Betz, Beate; Rautenberg, Christina; Haas, Rainer; Kobbe, Guido; Gattermann, Norbert; Germing, Ulrich Journal: Expert review of anticancer therapy Issue: Volume 20:Issue 8(2020) Page Start: 703 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. Influence of somatic mutations and pretransplant strategies in patients allografted for myelodysplastic syndrome or secondary acute myeloid leukemia. Issue 1 (30th October 2020) Authors: Rautenberg, Christina; Germing, Ulrich; Stepanow, Stefanie; Lauseker, Michael; Köhrer, Karl; Jäger, Paul S.; Geyh, Stefanie; Fan, Min; Haas, Rainer; Kobbe, Guido; Schroeder, Thomas Journal: American journal of hematology Issue: Volume 96:Issue 1(2021) Page Start: E15 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. Prognostic impact of pretransplant measurable residual disease assessed by peripheral blood WT1‐mRNA expression in patients with AML and MDS. (27th May 2021) Authors: Rautenberg, Christina; Lauseker, Michael; Kaivers, Jennifer; Jäger, Paul; Fischermanns, Carolin; Pechtel, Sabrina; Haas, Rainer; Kobbe, Guido; Germing, Ulrich; Schroeder, Thomas Journal: European journal of haematology Issue: Volume 107:Number 2(2021) Page Start: 283 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
10. Sorafenib and azacitidine as salvage therapy for relapse of FLT3‐ITD mutated AML after allo‐SCT. (2nd February 2017) Authors: Rautenberg, Christina; Nachtkamp, Kathrin; Dienst, Ariane; Schmidt, Pia Verena; Heyn, Claudia; Kondakci, Mustafa; Germing, Ulrich; Haas, Rainer; Kobbe, Guido; Schroeder, Thomas Journal: European journal of haematology Issue: Volume 98:Number 4(2017:Apr.) Page Start: 348 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗